Cannabis-based medicines for chronic neuropathic pain in adults.
The Cochrane database of systematic reviews January 19, 2026 Gülay Ateş, Patrick Welsch, Petra Klose et al. 5 citations
Estimates of the population prevalence of chronic pain with neuropathic components range from 6% to 10%. Current pharmacological treatments for neuropathic pain help only a minority. New treatments are needed. Cannabis is increasingly promoted in the media as a treatment for chronic pain. This is an update of a review first published in 2018. To assess the benefits and harms of cannabis-based...